Adherence to drug therapy in kidney disease

Por E.J.C. Magacho, L.C. Ribeiro, A. Chaoubah, M.G. Bastos
Publicado em 2011-03-01

Topical corticosteroids as adjunctive therapy for bacterial keratitis

Por Herretes, Samantha, Wang, Xue, Reyes, Johann MG
Publicado no Cochrane Database Syst Rev (2014)

Diagnostic accuracy of self-administered urine glucose test strips as a diabetes screening tool in a low-resource setting in Cambodia

Por Storey, Helen, L, van Pelt, Maurits H, Bun, Socheath, Daily, Frances, Neogi, Tina, Thompson, Matthew, McGuire, Helen, Weigl, Bernhard H
Publicado no BMJ Open (2018)

Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses

Por Halpin, David M.G., Birk, Ruby, Brealey, Noushin, Criner, Gerard J., Dransfield, Mark T., Hilton, Emma, Lomas, David A., Zhu, Chang-Qing, Lipson, David A.
Publicado no ERJ Open Res (2018)

Quality of care and quality of life of people with dementia living at green care farms: a cross-sectional study

Por de Boer, Bram, Hamers, Jan P.H., Zwakhalen, Sandra M.G., Tan, Frans E.S., Verbeek, Hilde
Publicado no BMC Geriatr (2017)

Effectiveness and safety of levosulpiride in the treatment of dysmotility-like functional dyspepsia

Por Lozano, R, Concha, MG Peralta, Montealegre, A, de Leon, L, Villalba, J Ortiz, Esteban, HO Lee, Cromeyer, M, García, JA Rivas, Brossa, A, Lluberes, G, Sandí, E Izquierdo, Quirós, H Burgos
Publicado em 2007

Double blind comparative study of omeprazole 10 mg and 30 mg daily for healing duodenal ulcers.

Por Prichard, P J, Rubinstein, D, Jones, D B, Dudley, F J, Smallwood, R A, Louis, W J, Yeomans, N D
Publicado em 1985

Cost-Effectiveness of Dabigatran (150 mg Twice Daily) and Warfarin in Patients ≥ 65 Years with Non-Valvular Atrial Fibrillation

Por Salata, Brian M, Hutton, David W, Levine, Deborah A, Froehlich, James B, Barnes, Geoffrey D
Publicado no J Med Econ (2013)

Pharmacokinetic and Pharmacodynamic Comparison of Once‐Daily Efavirenz (400 mg vs. 600 mg...

Por Dickinson, L, Amin, J, Else, L, Boffito, M, Egan, D, Owen, A, Khoo, S, Back, D, Orrell, C, Clarke, A, Losso, M, Phanuphak, P, Carey, D, Cooper, DA, Emery, S
Publicado no Clin Pharmacol Ther (2015)

Long-term retention on treatment with lumiracoxib 100 mg once or twice daily compared...

Por Fleischmann, Roy, Tannenbaum, Hyman, Patel, Neha P, Notter, Marianne, Sallstig, Peter, Reginster, Jean-Yves
Publicado em 2008

A phase III randomized controlled study on the efficacy and improved bowel function of prolonged‐release (PR) oxycodone‐naloxone (up to 160/80 mg daily) vs oxycodone PR

Por Dupoiron, D., Stachowiak, A., Loewenstein, O., Ellery, A., Kremers, W., Bosse, B., Hopp, M.
Publicado no Eur J Pain (2017)

Twice-daily amprenavir 1200 mg versus amprenavir 600 mg/ritonavir 100 mg, in combination with at least 2 other antiretroviral drugs, in HIV-1-infected patients

Por Nadler, Jeffrey P, Gathe, Joseph C, Pollard, Richard B, Richmond, Gary J, Liao, Qiming, Griffith, Sandy, Tracey Lancaster, C, Hernandez, Jaime E, Pappa, Keith A
Publicado em 2003

Acute treatment of duodenal ulcer: a multicentre study to compare ranitidine 150 mg twice daily with ranitidine 300 mg once at night.

Por Lee, F I, Reed, P I, Crowe, J P, McIsaac, R L, Wood, J R
Publicado em 1986

Long‐term efficacy and safety of oxycodone‐naloxone prolonged‐release formulation (up to 180/90 mg daily) – results of the open‐label extension phase of a phase III multicenter, multiple‐dose, randomized...

Por Dupoiron, D., Stachowiak, A., Loewenstein, O., Ellery, A., Kremers, W., Bosse, B., Hopp, M.
Publicado no Eur J Pain (2017)

COMPARATIVE EVALUATION OF THE ANTIHYPERTENSIVE EFFECT OF PERINDOPRIL AND LOSARTAN POTASSIUM...

Por O. A. Osipova, N. N. Kurbakov, A. G. Ovsyannikov, M. A. Vlasenko
Publicado em 2016-01-01

The role of tetracyclines in the treatment of non-specific urethritis.

Por Evans, B A
Publicado em 1977

Efavirenz 400 mg daily remains non-inferior to 600 mg: 96 week data from the double-blind, placebo-controlled ENCORE1 study

Por Carey, Dianne
Publicado no J Int AIDS Soc (2014)

The influence of non-selective arginase inhibitors on some reparative regeneration indexes of experimentally resected liver

Por Inga. M Kolesnik, Nina I Zhernakova, Olga A. Osipova, Galina A. Batischeva, Pavel A Galenko-Yaroshevsky, Alexander A. Dolzhikov
Publicado no Archivos Venezolanos de Farmacología y Terapéutica (2020)

Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis

Por Vic, P, Ategbo, S, Turck, D, Husson, M, Launay, V, Loeuille, G, Sardet, A, Deschildre, A, Druon, D, Arrouet-Lagande, C
Publicado em 1998

Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir...

Por Cooper, David A., Cordery, Damien V., Zajdenverg, Roberto, Ruxrungtham, Kiat, Arastéh, Keikawus, Bergmann, Frank, Neto, José L. de Andrade, Scherer, Joseph, Chaves, Ricardo L., Robinson, Patrick
Publicado no PLoS One (2016)